Premarket analyst action - healthcare

|By:, SA News Editor

Lantheus Holdings (NASDAQ:LNTH) initiated with Overweight rating and $22 (25% upside) price target by Cantor Fitzgerald.

Soligenix (NASDAQ:SNGX) initiated with Buy rating and $11 (431% upside) price target by H.C. Wainwright.

Trillium Therapeutics (NASDAQ:TRIL) initiated with Buy rating and $7 (132% upside) price target by H.C. Wainwright.

Cardiome Pharma (NASDAQ:CRME) upgraded to Buy with an $8 (70% upside) price target by Canaccord Genuity.

Healthcare Trust (NYSE:HTA) upgraded to Strong Buy by Raymond James.

Medical Properties (NYSE:MPW) upgraded to Market Perform with a $14 (10% upside) price target by JMP Securities.

Insulet (NASDAQ:PODD) downgraded to Neutral by BTIG Research.

Supernus Pharmaceuticals (NASDAQ:SUPN) downgraded to Neutral with a $46 (4% upside) price target by Piper Jaffray.